CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist

286.08
-3.07-1.06%

Market Closed Apr 30 15:00 CST

114.72BMarket Cap-62.72P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Biokin Pharmaceutical Q1 2025 Earnings Date

Currency：CNYApr 30, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	67.44M	--
		-98.77%
EPS	--	-1.33	--
		-110.66%

Analyst Rating

Strong Buy

May 3, 2025

Sichuan Biokin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/FY	-- / 2.588B	--
--	2025/FY	-- / 2.243B	--
Mar 29, 2025	2024/FY	5.823B / 6.051B	--
--	2023/FY	561.871M / 562.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2026/FY-- / 2.588B--

--2025/FY-- / 2.243B--

Mar 29, 20252024/FY5.823B / 6.051B--

--2023/FY561.871M / 562.000M--

--------

Unlock Free Earnings Estimates

Open Account

Sichuan Biokin Pharmaceutical Earnings Reports

Baili Tianheng: Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Report for the first quarter of 2025

Apr 29 12:00 ET

Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Report for the first quarter of 2025

Apr 29 12:00 ET

SiChuan Baili Tianheng Pharmaceutical Co., Ltd. 2024 Annual Report.

Mar 28 12:00 ET

Summary of the 2024 Annual Report of SiChuan Baili Tianheng Pharmaceutical Co., Ltd.